Neurostimulation Pelvic Nerves
Neurostimulation is a young and dynamic
medical field with
a wide range of different approaches.
Mission to help millions of patients
NeuroGyn AG is developing new innovative solutions in the domain of neurotechnology for the international medical markets with the mission to improve the quality of life for hundreds of millions of patients. NeuroGyn’s products are the result of modern R&D based on the latest findings in the Neuropelveology & Women Health. NeuroGyn has the US-patent right on laparoscopic (LION procedures) and vaginal implantation (GNS-therapy) of neuroprothesis to the pelvic nerves with corresponding indications. The clinical effectiveness of these therapies no longer needs to be proven but requires the development of an appropriate neuroprothesis. This neuroprothesis bases on requirements for clinicians and is designed for both the LION and GNS procedures. NeuroGyn holds the international/EU/US licensing rights for own neuroprothesis and surgical „applicators“.
Prof. Prof. h.c. (China) Dr. med. Marc Possover, MD, PhD
Founder & Chief Scientific Officer
NeuroGyn AG is a stock corporation founded 2014 with Legal seat is Baar, Zug/Switzerland. Company status: Active Legal form: Company limited by shares (AG) Sector: Research and development Arbachstrasse 2, 6340 Baar UID: CHE-179.779.542 Commercial register number: CH-170.3.039.165-0